Correction to: LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells

被引：0
|
作者：
Weidong Li
Xuesong Dong
Changjun He
Gang Tan
Ziyi Li
Bo Zhai
Jing Feng
Xian Jiang
Chang Liu
Hongchi Jiang
Xueying Sun
机构：
[1] The First Affiliated Hospital of Harbin Medical University,The Hepatosplenic Surgery Center
[2] The Fourth Affiliated Hospital of Harbin Medical University,Department of General Surgery
[3] The Third Affiliated Hospital of Harbin Medical University,Department of Surgery
来源：
Journal of Experimental & Clinical Cancer Research | / 40卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Overexpression of the lncRNA HOTAIRM1 promotes lenvatinib resistance by downregulating miR-34a and activating autophagy in hepatocellular carcinoma
    Danyan Gu
    Meng Tong
    Jing Wang
    Bocheng Zhang
    Jinghua Liu
    Guoqiang Song
    Biao Zhu
    Discover Oncology, 14
  • [42] Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK/PI3K/AKT signaling
    P-F Zhang
    K-S Li
    Y-h Shen
    P-T Gao
    Z-R Dong
    J-B Cai
    C Zhang
    X-Y Huang
    M-X Tian
    Z-Q Hu
    D-M Gao
    J Fan
    A-W Ke
    G-M Shi
    Cell Death & Disease, 2016, 7 : e2201 - e2201
  • [43] EFFECT OF ERK1/2 SIGNALING PATHWAY REGULATED BY MIR-21 ON PROLIFERATION, APOPTOSIS AND INVASION OF RENAL CELL, CARCINOMA
    Zhao, Yanjun
    Xie, Rui
    Wang, Jianping
    Wu, Fan
    ACTA MEDICA MEDITERRANEA, 2019, 35 (04): : 1943 - 1948
  • [44] Quantitative proteomics identifies FOLR1 to drive sorafenib resistance via activating autophagy in hepatocellular carcinoma cells
    Chu, Hongwei
    Wu, Changqing
    Zhao, Qun
    Sun, Rui
    Yang, Kuo
    Zhao, Baofeng
    Liu, Yang
    Liang, Zhen
    Zhong, Shijun
    Zhang, Lihua
    Zhang, Yukui
    CARCINOGENESIS, 2021, 42 (05) : 753 - 761
  • [45] Torin2 overcomes sorafenib resistance via suppressing mTORC2-AKT-BAD pathway in hepatocellular carcinoma cells
    Yi-Ting Hu
    Zhe-Yue Shu
    Jing-Hua Jiang
    Qin-Fen Xie
    Shu-Sen Zheng
    Hepatobiliary&PancreaticDiseasesInternational, 2020, 19 (06) : 547 - 554
  • [46] Torin2 overcomes sorafenib resistance via suppressing mTORC2-AKT-BAD pathway in hepatocellular carcinoma cells
    Hu, Yi-Ting
    Shu, Zhe-Yue
    Jiang, Jing-Hua
    Xie, Qin-Fen
    Zheng, Shu-Sen
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2020, 19 (06) : 547 - 554
  • [47] LncRNA TUG1 interacting with miR-144 contributes to proliferation, migration and tumorigenesis through activating the JAK2/STAT3 pathway in hepatocellular carcinoma
    Lv, Jun
    Kong, Yongkui
    Gao, Zhiqiang
    Liv, Yanmin
    Zhu, Pengfei
    Yu, Zujian
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2018, 101 : 19 - 28
  • [48] miR-181a induces sorafenib resistance of hepatocellular carcinoma cells through downregulation of RASSF1 expression
    Azumi, Junya
    Tsubota, Toshiaki
    Sakabe, Tomohiko
    Shiota, Goshi
    CANCER SCIENCE, 2016, 107 (09) : 1256 - 1262
  • [49] Upregulated UCA1 contributes to oxaliplatin resistance of hepatocellular carcinoma through inhibition of miR-138-5p and activation of AKT/mTOR signaling pathway
    Huang, Guolin
    Li, Li
    Liang, Chaoyong
    Yu, Fei
    Teng, Cuifang
    Pang, Yingxing
    Wei, Tongtong
    Song, Jinjing
    Wang, Hanlin
    Liao, Xiaoli
    Li, Yongqiang
    Yang, Jie
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2021, 9 (01):
  • [50] Involvement of HIF-1α-regulated miR-21, acting via the Akt/NF-κB pathway, in malignant transformation of HBE cells induced by cigarette smoke extract
    Lu, Lu
    Xu, Hui
    Yang, Ping
    Xue, Junchao
    Chen, Chao
    Sun, Qian
    Yang, Qianlei
    Lu, Jiachun
    Shi, Aimin
    Liu, Qizhan
    TOXICOLOGY LETTERS, 2018, 289 : 14 - 21
12345